The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A. Voors, Piotr Ponikowski, C. Jan Willem Borleffs et al.|Nature Medicine|2022Cited by 889
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trialJan Biegus, Piotr Ponikowski, Adriaan A. Voors et al.|European Heart Journal|2022Cited by 213
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail Kosiborod, Adriaan A. Voors, Christiane E. Angermann et al.|Circulation|2022Cited by 142
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across EuropeMateusz Sokolski, Piotr Ponikowski, Piotr Gajewski et al.|The American Journal of Medicine|2020Cited by 71
Elevated lactate in acute heart failure patients with intracellular iron deficiency as identifier of poor outcomeJan Biegus, Piotr Ponikowski|Kardiologia Polska|2019Cited by 32